Impacts of age on plasma monoamine metabolite concentrations in a large cohort of healthy individuals

Psychiatry Research

Volumn 220, Issue 1-2, 2014, Pages 639-645

  Soda, Emi ^a   Miura, Itaru ^a,b   Hoshino, Hiroshi ^a   Kanno Nozaki, Keiko ^a   Ota, Takafumi ^a   Oguchi, Haruka ^a   Watanabe, Kenya ^a   Yang, Qiaohui ^a   Mashiko, Hirobumi ^a   Niwa, Shin Ichi ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b ZUCKER HILLSIDE HOSPITAL   (United States)

Author keywords

3 methoxy 4 hydroxyphenylglycol sulfate; 3 methoxy 4 hydroxyphenylglycol sulfate conjugate; Age factors; Homovanillic acid; Hydroxyindoleacetic acid; Plasma

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; 5 HYDROXYINDOLEACETIC ACID; AMINE OXIDASE (FLAVIN CONTAINING); HOMOVANILLIC ACID;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGING; ARTICLE; BLOOD LEVEL; BRAIN FUNCTION; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; KIDNEY FUNCTION; MALE; MONOAMINE METABOLISM; NORMAL HUMAN; SEX DIFFERENCE; AGE; BLOOD; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HOMOVANILLIC ACID; HUMANS; HYDROXYINDOLEACETIC ACID; MALE; METHOXYHYDROXYPHENYLGLYCOL; MIDDLE AGED; MONOAMINE OXIDASE; SEX FACTORS; YOUNG ADULT;

EID: 84908202368     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2014.08.031     Document Type: Article

References (46)

1. Amin F., Davison M., Davis K.L. Homovanillic acid measurement in clinical research: a review of methodology. Schizophrenia Bulletin 1992, 18:123-148.
2. Asberg M., Thorén P., Träskman L., Bertilsson L., Ringberger V. "Serotonin depression"-a biochemical subgroup within the affective disorders?. Science 1976, 191:478-480.
3. Azorin J.M., Raucoules D., Valli M., Levy C., Lancon C., Luccioni J.M., Tissot R. Plasma levels of 3-methoxy-4-hydroxyphenylglycol in depressed patients compared with normal controls. Neuropsychobiology 1990, 23:18-24.
4. Beckmann H., Goodwin F.K. Antidepressant response to tricyclics and urinary MHPG in unipolar patients. Clinical response to imipramine or amitriptyline. Archives of General Psychiatry 1975, 32:17-21.
5. Blennow K., Wallin A., Gottfries C.G., Karlsson I., Månsson J.E., Skoog I., Wikkelsö C., Svennerholm L. Cerebrospinal fluid monoamine metabolites in 114 healthy individuals 18-88 years of age. European Neuropsychopharmacology 1993, 3:55-61.
6. Carlsson M., Svensson K., Eriksson E., Carlsson A. Rat brain serotonin: biochemical and functional evidence for a sex difference. Journal of Neural Transmission 1985, 63:297-313.
7. Cockcroft D.W., Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 1976, 16:31-41.
8. Cole M., Craft A.W., Parker L., Bell S., Seviour J.A., McGill A.C., Dale G. Urinary creatinine adjusted reference ranges for homovanillic and vanillylmandelic acid in children and adults. Clinica Chimica Acta 1995, 236:19-32.
9. Dalmaz Y., Peyrin L. Sex-differences in catecholamine metabolites in human urine during development and at adulthood. Journal of Neural Transmission 1982, 54:193-207.
10. Davis B.A., Durden D.A., O'Reilly R.L. The effect of age, sex, weight and height on the plasma concentrations in healthy subjects of the acidic metabolites of some biogenic monoamines involved in psychiatric and neurological disorders. Progress in Neuro-Psychopharmacology & Biological Psychiatry 1991, 15:503-512.
11. Eklundh T., Gunnarsson T., Nordin C. Monoamine compounds in cerebrospinal fluid of healthy subjects punctured without preceding strict bed rest: a pilot study. Neuropsychobiology 2001, 43:5-10.
12. Fowler C.J., Wiberg A., Oreland L., Marcusson J., Winblad B. The effect of age on the activity and molecular properties of human brain monoamine oxidase. Journal of Neural Transmission 1980, 49:1-20.
13. Galva M.D., Bondiolotti G.P., Olasmaa M., Picotti G.B. Effect of aging on lazabemide binding, monoamine oxidase activity and monoamine metabolites in human frontal cortex. Journal of Neural Transmission. General Section 1995, 101:83-94.
14. Geracioti T.D., West S.A., Baker D.G., Hill K.K., Ekhator N.N., Wortman M.D., Keck P.E., Norman A.B. Low CSF concentration of a dopamine metabolite in tobacco smokers. American Journal of Psychiatry 1999, 156:130-132.
15. Gerhardt G.A., Drebing C.J., Freedman R. Simultaneous determination of free homovanillic acid, (3-methoxy-4-hydroxyphenyl) ethylene glycol, and vanilmandelic acid in human plasma by high-performance liquid chromatography coupled with dual-electrode coulometric electrochemical detection. Analytical Chemistry 1986, 58:2879-2883.
16. Golden R.N., Gilmore J.H., Ekstrom R.D., Knight B., Ruegg R.G., Miller H.L., Carson S.W. The effects of age, gender, and season on serotonergic function in healthy subjects. Progress in Neuro-Psychopharmacology & Biological Psychiatry 1996, 20:1315-1323.
17. Gottfries C.G., Gottfries I., Johansson B., Olsson R., Persson T., Roos B.E., Sjöström R. Acid monoamine metabolites in human cerebrospinal fluid and their relations to age and sex. Neuropharmacology 1971, 10:665-672.
18. Halbreich U., Sharpless N., Asnis G.M., Endicott J., Goldstein S., Vital-Herne J., Eisenberg J., Zander K., Kang B.J., Shindledecker R., Yeh CM. Afternoon continuous plasma levels of 3-methoxy-4-hydroxyphenylglycol and age. Distinctive biologic subgroups of endogenous depression?. Archives of General Psychiatry 1987, 44:804-812.
19. Hartikainen P., Soininen H., Reinikainen K.J., Sirviö J., Soikkeli R., Riekkinen P.J. Neurotransmitter markers in the cerebrospinal fluid of normal subjects. Effects of aging and other confounding factors. Journal of Neural Transmission General Section 1991, 84:103-117.
20. Jernej B., Banović M., Cicin-Sain L., Hranilović D., Balija M., Oresković D., Folnegović-Smalc V. Physiological characteristics of platelet/circulatory serotonin: study on a large human population. Psychiatry Research 2000, 94:153-162.
21. Jimerson D.C., Ballenger J.C., Lake C.R., Post R.M., Goodwin F.K., Kopin I.J. Plasma and CSF MHPG in normals. Psychopharmacology Bulletin 1981, 17:86-87.
22. Jönsson E., Sedvall G., Brené S., Gustavsson J.P., Geijer T., Terenius L., Crocq M.-A., Lannfelt L., Tylec A., Sokoloff P., Schwartz J.C., Wiesel F.-A. Dopamine-related genes and their relationships to monoamine metabolites in CSF. Biological Psychiatry 1996, 40:1032-1043.
23. Kelly M.E., Yao J.K., van Kammen D.P. Plasma catecholamine metabolites as markers for psychosis and antipsychotic response in schizophrenia. Neuropsychopharmacology 1999, 20:603-611.
24. Kopin I.J., Gordon E.K., Jimerson D.C., Polinsky R.J. Relation between plasma and cerebrospinal fluid levels of 3-methoxy-4-hydroxyphenylglycol. Science 1983, 219:73-75.
25. Köster G., Breuer H., Schneider H.T. Effect of 2-substituted oestrogens in vivo on the metabolism of noradrenaline in rat brain. Acta Endocrinologica (Copenhagen) 1982, 99:1-8.
26. Kumar A.M., Weiss S., Fernandez J.B., Cruess D., Eisdorfer C. Peripheral serotonin levels in women: role of aging and ethnicity. Gerontology 1998, 44:211-216.
27. Lambert G.W., Eisenhofer G., Esler M.D. The influence of aging on the plasma concentration and renal clearance of homovanillic acid. Psychoneuroendocrinology 1994, 19:33-41.
28. Luine V.N., Khylchevskaya R.I., McEwen B.S. Effect of gonadal steroids on activities of monoamine oxidase and choline acetylase in rat brain. Brain Research 1975, 86:293-306.
29. Luykx J.J., Bakker S.C., Lentjes E., Boks M.P., van Geloven.N., Eijkemans M.J., Janson E., Strengman E., de Lepper A.M., Westenberg H., Klopper K.E., Hoorn H.J., Gelissen H.P., Jordan J., Tolenaar N.M., van Dongen E.P., Michel B., Abramovic L., Horvath S., Kappen T., Bruins P., Keijzers P., Borgdorff P., Ophoff R.A., Kahn R.S Season of sampling and season of birth influence serotonin metabolite levels in human cerebrospinal fluid. PLoS ONE 2012, 7:e30497.
30. Maas J.W., Hattox S.E., Greene N.M., Landis D.H. Estimates of dopamine and serotonin synthesis by the awake human brain. Journal of Neurochemistry 1980, 34:1547-1549.
31. Miura I., Takeuchi S., Katsumi A., Mori A., Kanno K., Yang Q., Mashiko H., Numata Y., Niwa S. Effects of aripiprazole and the Taq1A polymorphism in the dopamine D2 receptor gene on the clinical response and plasma monoamine metabolites level during the acute phase of schizophrenia. Journal of Clinical Psychopharmacology 2012, 32:106-109.
32. Nagaoka S., Iwamoto N., Arai H. First-episode neuroleptic-free schizophrenics: Concentration of monoamines and their metabolites in plasma and their correlations with clinical responses to haloperidol treatment. Biological Psychiatry 1997, 41:857-864.
33. Oades R.D., Slusarek M., Velling S., Bondy B. Serotonin platelet-transporter measures in childhood attention-deficit/hyperactivity disorder (ADHD): clinical versus experimental measures of impulsivity. World Journal of Biological Psychiatry 2002, 3:96-100.
34. Ortiz J., Artigas F., Gelpí E. Serotonergic status in human blood. Life Sciences 1988, 43:983-990.
35. Ortiz J., Martínez E., Gelpí E., Artigas F. Rapid non-enzymatic HPLC determination of total MHPG in human plasma. Life Sciences 1990, 46:239-246.
36. Palmer A.M., Sims N.R., Bowen D.M., Neary D., Palo J., Wikstrom J., Davison A.N. Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia. Journal of Neurology, Neurosurgery, and Psychiatry 1984, 47:481-484.
37. Potter W.Z., Hsiao J.K., Goldman S.M. Effects of renal clearance on plasma concentrations of homovanillic acid. Methodologic cautions. Archives of General Psychiatry 1989, 46:558-562.
38. Robinson D.S., Davis J.M., Nies A., Ravaris C.L., Sylwester D. Relation of sex and aging to monoamine oxidase activity of human brain, plasma, and platelets. Archives of General Psychiatry 1971, 24:536-539.
39. Saura J., Andrés N., Andrade C., Ojuel J., Eriksson K., Mahy N. Biphasic and region-specific MAO-B response to aging in normal human brain. Neurobiology of Aging 1997, 18:497-507.
40. Shinkai K., Yoshimura R., Ueda N., Okamoto K., Nakamura J. Associations between baseline plasma MHPG (3-methoxy-4-hydroxyphenylglycol) levels and clinical responses with respect to milnacipran versus paroxetine treatment. Journal of Clinical Psychopharmacology 2004, 24:11-17.
41. Sumiyoshi T., Hasegawa M., Jayathilake K., Meltzer H.Y. Sex differences in plasma homovanillic acid levels in schizophrenia and normal controls: relation to neuroleptic resistance. Biological Psychiatry 1997, 41:560-569.
42. Tohgi H., Takahashi S., Abe T. The effect of age on concentrations of monoamines, amino acids, and their related substances in the cerebrospinal fluid. Journal of Neural Transmission. Parkinson's Disease and Dementia Section 1993, 5:215-226.
43. Ueda N., Yoshimura R., Shinkai K., Sakata Y., Nakamura J. Higher plasma 5-hydroxyindoleacetic acid levels are associated with SSRI-induced nausea. Neuropsychobiology 2003, 48:31-34.
44. Volchegorskii I.A., Shemyakov S.E., Turygin V.V., Malinovskaya N.V. Comparative analysis of age-related changes in activities of monoamine oxidase-B and antioxidant defense enzymes in various structures of human brain. Bulletin of Experimental Biology and Medicine 2001, 132:760-762.
45. Whelton C.L., Gupta R.N., Cleghorn J.M., Ballagh S.R. Influence of renal clearance on peripheral homovanillic acid measurements in healthy subjects and schizophrenic patients. Schizophrenia Research 1993, 11:33-40.
46. Wode-Helgodt B., Sedvall G. Correlations between height of subject and concentrations of monoamine metabolites in cerebrospinal fluid from psychotic men and women. Communications in Psychopharmacology 1978, 2:177-183.